Ebola Hemorrhagic Fever and Current State of Vaccine Development
In February 2014, the first outbreak case of Ebola virus was confirmed and registered in the region occurred of Guinea (West -Africa) by WHO. By July 31st, the total number of suspected and confirmed cases in the Ebola Hemorrhagic Fever (EHF) outbreak had increased to 1 323, including 729 deaths at a fatality rate of 55% in the southeastern area of Guinea, Sierra Leone, Liberia, and Nigeria [1]. The Ebola virus in Guinea showed 98% homology with Zaire Ebola Virus (ZEBOV) found in Congo and Gabon (1994-1995) [2].
Source: Osong Public Health and Research Perspectives - Category: Global & Universal Authors: Joo Eun Hong, Kee-Jong Hong, WooYoung Choi, Won-Ja Lee, Yeon Hwa Choi, Chung-Hyeon Jeong, Kwang-il CHO Tags: Brief Report Source Type: research
More News: African Health | Ebola | Ebola Vaccine | Gabon Health | International Medicine & Public Health | Outbreaks | Vaccines